RxDoctor Payments Data

Zaka Khan

Clinical Cardiac Electrophysiology · Sugar Land, TXNPI 1093048969

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 48.4% of the total. Reporting peaked in 2019 at $5,317 and has fallen 77.2% since, to $1,214 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TX, where the typical reported total is $27,892.

$19,671in general payments, 2019–2025

Across 250 payments — averaging $78.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$10K
  • Boston Scientific$4K
  • Intuitive Surgical$2K
  • Medtronic$2K
  • Biotronik Inc.$850
  • Biosense Webster, Inc.$358
  • plus $941 from 12 others

What the payments were for

  • Travel & lodging$8,30642%
  • Food & beverage$11,34158%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,671 in reported general payments places this provider in the 35th percentile of 233 clinical cardiac electrophysiology providers in Texas.

See all clinical cardiac electrophysiology providers in Texas →

Medicare billing

Part B allowed, 2024
$204,495
Medicare patients
248
Services billed
1,801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban210$222,472
XareltoRivaroxaban60$67,483
Amiodarone Hcl206$3,957
Dofetilide14$2,178
Metoprolol Succinate207$1,903
SotalolSotalol Hcl36$594
Metoprolol Tartrate71$521
Ranolazine ErRanolazine12$489
Carvedilol68$445
Losartan Potassium35$389
Flecainide Acetate23$389
ClopidogrelClopidogrel Bisulfate35$363
Minocycline Hcl44$274
Lisinopril36$258
Atorvastatin Calcium35$239

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Sugar Land

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →